Mesterolone
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
| | |
| Mesterolone
| |
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | G03 |
| PubChem | |
| Chemical data | |
| Formula | C20H32O2 |
| Mol. mass | 304.467 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Mesterolone | |
|
Articles | |
|---|---|
|
Most recent articles on Mesterolone Most cited articles on Mesterolone | |
|
Media | |
|
Powerpoint slides on Mesterolone | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Mesterolone at Clinical Trials.gov Clinical Trials on Mesterolone at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Mesterolone
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Mesterolone Discussion groups on Mesterolone Patient Handouts on Mesterolone Directions to Hospitals Treating Mesterolone Risk calculators and risk factors for Mesterolone
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Mesterolone | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Mesterolone is an orally applicable androgen, and DHT derivative. It is sold under the brand name Proviron, by Schering. In the late 70's and early 80's it was used with some success in controlled studies of men suffering from various forms of depression.
In one randomized, double-blind 4-week trial, 38 dysthymic men were administered 75mg daily. Itil & Colleagues reported an improvement of symptoms which included anxiety, lack of drive and desire. Next, they administered a high dose (450mg/day) or placebo in a 6-week randomized trial of 52 men with a mean age of 40 years, suffering from dysthymia, unipolar and bipolar depression. Both the mesterolone and placebo groups improved significantly and there were no statistically significant differences between the two groups. In this series of studies mesterolone lead to a significant decrease in LH and testosterone levels. This is probably as a result of the extremely high dose used. In another, 100mg mesterolone cipionate was administered twice monthly. With regards to plasma T levels, there was no difference between the treated vs untreated group, and baseline LH levels were minimally affected.[1]
Mesterolone is a relatively weak androgen and rarely used for replacement therapies.[2]
References
- ↑ Archives of Dermatological Research (1977), Testosterone levels and gonadotrophins in klinefelter's patients treated with injections of mesterolone cipionate
- ↑ Human Reproduction Update (2004), Testosterone replacement therapy: current trends and future directions
- Frances Morrison, Mary. (2000) Hormones, Gender and the Aging Brain: The Endocrine Basis of Geriatric Psychiatry, Page 134, Cambridge University Press. ISBN 0521653045.
- Itil et al. The effects of mesterolone, a male sex hormone in depressed patients. 1984.
WikiDoc Research Resources for Mesterolone | |
|---|---|
| Articles on Mesterolone | Most recent articles on Mesterolone • Most cited articles on Mesterolone • Review articles on Mesterolone • Articles on Mesterolone in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Mesterolone | Powerpoint slides on Mesterolone • Images of Mesterolone • Photos of Mesterolone • Podcasts & MP3s on Mesterolone • Videos on Mesterolone |
| Evidence Based Medicine Regarding Mesterolone | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Mesterolone • Bandolier on Mesterolone • TRIP on Mesterolone |
| Cost Effectiveness of Mesterolone | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Mesterolone | list5 = Ongoing Trials on Mesterolone at Clinical Trials.gov • Trial results on Mesterolone • Clinical Trials on Mesterolone at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Mesterolone
| list6 = US National Guidelines Clearinghouse on Mesterolone • NICE Guidance on Mesterolone • NHS PRODIGY Guidance • FDA on Mesterolone • CDC on Mesterolone
| group7 = Textbook Information on Mesterolone
| list7 = Books and Textbook Information on Mesterolone
| group8 = Pharmacology Resources on Mesterolone
| list8 =
AND (Dose)}} Dosing of Mesterolone • AND (drug interactions)}} Drug interactions with Mesterolone • AND (side effects)}} Side effects of Mesterolone • AND (Allergy)}} Allergic reactions to Mesterolone • AND (overdose)}} Overdose information on Mesterolone • AND (carcinogenicity)}} Carcinogenicity information on Mesterolone • AND (pregnancy)}} Mesterolone in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Mesterolone •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Mesterolone
| list9 =
AND (pharmacogenomics)}} Genetics of Mesterolone • AND (pharmacogenomics)}} Pharmacogenomics of Mesterolone • AND (proteomics)}} Proteomics of Mesterolone
| group10 = Newstories on Mesterolone
| list10 = Mesterolone in the news • Be alerted to news on Mesterolone • News trends on Mesterolone</small>
| group11 = Commentary on Mesterolone
| list11 =
Blogs on Mesterolone
| group12 = Patient Resources on Mesterolone | list12 = Patient resources on Mesterolone • Discussion groups on Mesterolone • Patient Handouts on Mesterolone • Directions to Hospitals Treating Mesterolone • Risk calculators and risk factors for Mesterolone
| group13 = Healthcare Provider Resources on Mesterolone
| list13 =
Symptoms of Mesterolone • Causes & Risk Factors for Mesterolone • Diagnostic studies for Mesterolone • Treatment of Mesterolone
| group14 = Continuing Medical Education (CME) Programs on Mesterolone | list14 = CME Programs on Mesterolone
| group15 = International Resources on Mesterolone | list15 = Mesterolone en Espanol • Mesterolone en Francais
| group16 = Business Resources on Mesterolone | list16 = Mesterolone in the Marketplace • Patents on Mesterolone
| group17 = Informatics Resources on Mesterolone | list17 = List of terms related to Mesterolone
}}
Anabolic steroids (A14) (trademark names in brackets) | |
|---|---|
| Androstan (carbon 19 present) | Androstadienone • Boldenone undecylenate (Equipoise) • 4-Chlordehydromethyltestosterone (Turinabol) • Clostebol • Desoxymethyltestosterone (Madol) • DHEA • DHT • Drostanolone (Masteron) • Fluoxymesterone (Halotestin) • Furazabol (Miotolan) • Methandrostenolone (Dianabol) • Methenolone • Mesterolone (Proviron) • Methenolone enanthate (Primobolan) • Mestanolone • Norethandrolone • Oxandrolone (Anavar) • Oxymetholone (Anadrol) • Oxymetholone (Anadrol-50) • Quinbolone (Anabolicum Vister) • Stanozolol (Winstrol) • Testosterone |
| Estren (carbon 19 absent) | Ethylestrenol • Mibolerone (Cheque Drops) • Nandrolone (Deca Durabolin) • Norbolethone (Genabol) • Oxabolone cipionate • Tetrahydrogestrinone (The Clear) • Trenbolone (Fina) |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies